Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $22.5 million.

  • Rallybio's Other Non Operating Income rose 885577.69% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year increase of 375134.23%. This contributed to the annual value of $744000.0 for FY2024, which is 18396.95% up from last year.
  • As of Q3 2025, Rallybio's Other Non Operating Income stood at $22.5 million, which was up 885577.69% from $118000.0 recorded in Q2 2025.
  • Rallybio's 5-year Other Non Operating Income high stood at $22.5 million for Q3 2025, and its period low was $35000.0 during Q4 2023.
  • Over the past 3 years, Rallybio's median Other Non Operating Income value was $143000.0 (recorded in 2024), while the average stood at $2.2 million.
  • Examining YoY changes over the last 5 years, Rallybio's Other Non Operating Income showed a top increase of 885577.69% in 2025 and a maximum decrease of 1748.25% in 2025.
  • Quarter analysis of 3 years shows Rallybio's Other Non Operating Income stood at $35000.0 in 2023, then soared by 422.86% to $183000.0 in 2024, then surged by 12183.61% to $22.5 million in 2025.
  • Its Other Non Operating Income was $22.5 million in Q3 2025, compared to $118000.0 in Q2 2025 and $174000.0 in Q1 2025.